Efficacy and safety of casopitant mesylate, a neurokinin 1 (NK1)-receptor antagonist, in prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemotherapy: a randomised, double-blind, placebo-controlled trial
Autor: | Grunberg, Steven M, Rolski, Janusz, Strausz, Janos, Aziz, Zeba, Lane, Stephen, Russo, Mark W, Wissel, Paul, Guckert, Mary, Wright, Oliver, Herrstedt, Jørn |
---|---|
Zdroj: | In Lancet Oncology 2009 10(6):549-558 |
Databáze: | ScienceDirect |
Externí odkaz: |